For decades cancer drugmakers have taken a more-is-more model when dosing drugs in clinical trials. U.S. regulators want them to reconsider that approach.
Read full story (WSJ subscription required)>
Author:
-
-
Is Elon Musk is an Illegal Immigrant? Yes. So is Melania Trump.
-
Was Donald “Krasnov” Trump Recruited by the KGB in 1987?
-
What are Ukraine’s rare minerals, and why is Trump eyeing them?
-
Amid staff cuts and budget chaos, more than 700 national park employees take buyout
-
Utah could become the first state to ban fluoride in its drinking water
-
What Can House Republicans Cut Instead of Medicaid? Not Much.
-
‘Time for Him to Go’: New Yorkers Sour on Eric Adams
